Global Meningococcal Polysaccharide Vaccine Supply, Demand and Key Producers, 2023-2029

Page: 103

Published Date: 24 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

The global Meningococcal Polysaccharide Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Meningococcal polysaccharide diphtheria conjugate vaccine is an active immunizing agent used to prevent infection by certain groups of meningococcal bacteria.

This report studies the global Meningococcal Polysaccharide Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Meningococcal Polysaccharide Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Meningococcal Polysaccharide Vaccine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Meningococcal Polysaccharide Vaccine total production and demand, 2018-2029, (K Doses)
Global Meningococcal Polysaccharide Vaccine total production value, 2018-2029, (USD Million)
Global Meningococcal Polysaccharide Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Doses)
Global Meningococcal Polysaccharide Vaccine consumption by region & country, CAGR, 2018-2029 & (K Doses)
U.S. VS China: Meningococcal Polysaccharide Vaccine domestic production, consumption, key domestic manufacturers and share
Global Meningococcal Polysaccharide Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Doses)
Global Meningococcal Polysaccharide Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Doses)
Global Meningococcal Polysaccharide Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Doses)
This reports profiles key players in the global Meningococcal Polysaccharide Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Bio-Med, CanSinoBIO, Walvax Biotechnology, Chongqing Zhifei Biological, Chengdu Kanghua Biological Products, Changsheng Biotechnology and CanSinoBIO, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Meningococcal Polysaccharide Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Doses) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Meningococcal Polysaccharide Vaccine Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Meningococcal Polysaccharide Vaccine Market, Segmentation by Type
    Polysaccharide Meningtitis AC
    Meningitis ACYW

Global Meningococcal Polysaccharide Vaccine Market, Segmentation by Application
    6 Months-15Year
    over 3 Year
    over 2 Year
    over 3 Months

Companies Profiled:
    Sanofi
    Bio-Med
    CanSinoBIO
    Walvax Biotechnology
    Chongqing Zhifei Biological
    Chengdu Kanghua Biological Products
    Changsheng Biotechnology
    CanSinoBIO

Key Questions Answered
1. How big is the global Meningococcal Polysaccharide Vaccine market?
2. What is the demand of the global Meningococcal Polysaccharide Vaccine market?
3. What is the year over year growth of the global Meningococcal Polysaccharide Vaccine market?
4. What is the production and production value of the global Meningococcal Polysaccharide Vaccine market?
5. Who are the key producers in the global Meningococcal Polysaccharide Vaccine market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Meningococcal Polysaccharide Vaccine Introduction
    1.2 World Meningococcal Polysaccharide Vaccine Supply & Forecast
        1.2.1 World Meningococcal Polysaccharide Vaccine Production Value (2018 & 2022 & 2029)
        1.2.2 World Meningococcal Polysaccharide Vaccine Production (2018-2029)
        1.2.3 World Meningococcal Polysaccharide Vaccine Pricing Trends (2018-2029)
    1.3 World Meningococcal Polysaccharide Vaccine Production by Region (Based on Production Site)
        1.3.1 World Meningococcal Polysaccharide Vaccine Production Value by Region (2018-2029)
        1.3.2 World Meningococcal Polysaccharide Vaccine Production by Region (2018-2029)
        1.3.3 World Meningococcal Polysaccharide Vaccine Average Price by Region (2018-2029)
        1.3.4 North America Meningococcal Polysaccharide Vaccine Production (2018-2029)
        1.3.5 Europe Meningococcal Polysaccharide Vaccine Production (2018-2029)
        1.3.6 China Meningococcal Polysaccharide Vaccine Production (2018-2029)
        1.3.7 Japan Meningococcal Polysaccharide Vaccine Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Meningococcal Polysaccharide Vaccine Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Meningococcal Polysaccharide Vaccine Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Meningococcal Polysaccharide Vaccine Demand (2018-2029)
    2.2 World Meningococcal Polysaccharide Vaccine Consumption by Region
        2.2.1 World Meningococcal Polysaccharide Vaccine Consumption by Region (2018-2023)
        2.2.2 World Meningococcal Polysaccharide Vaccine Consumption Forecast by Region (2024-2029)
    2.3 United States Meningococcal Polysaccharide Vaccine Consumption (2018-2029)
    2.4 China Meningococcal Polysaccharide Vaccine Consumption (2018-2029)
    2.5 Europe Meningococcal Polysaccharide Vaccine Consumption (2018-2029)
    2.6 Japan Meningococcal Polysaccharide Vaccine Consumption (2018-2029)
    2.7 South Korea Meningococcal Polysaccharide Vaccine Consumption (2018-2029)
    2.8 ASEAN Meningococcal Polysaccharide Vaccine Consumption (2018-2029)
    2.9 India Meningococcal Polysaccharide Vaccine Consumption (2018-2029)

3 World Meningococcal Polysaccharide Vaccine Manufacturers Competitive Analysis
    3.1 World Meningococcal Polysaccharide Vaccine Production Value by Manufacturer (2018-2023)
    3.2 World Meningococcal Polysaccharide Vaccine Production by Manufacturer (2018-2023)
    3.3 World Meningococcal Polysaccharide Vaccine Average Price by Manufacturer (2018-2023)
    3.4 Meningococcal Polysaccharide Vaccine Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Meningococcal Polysaccharide Vaccine Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Meningococcal Polysaccharide Vaccine in 2022
        3.5.3 Global Concentration Ratios (CR8) for Meningococcal Polysaccharide Vaccine in 2022
    3.6 Meningococcal Polysaccharide Vaccine Market: Overall Company Footprint Analysis
        3.6.1 Meningococcal Polysaccharide Vaccine Market: Region Footprint
        3.6.2 Meningococcal Polysaccharide Vaccine Market: Company Product Type Footprint
        3.6.3 Meningococcal Polysaccharide Vaccine Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Meningococcal Polysaccharide Vaccine Production Value Comparison
        4.1.1 United States VS China: Meningococcal Polysaccharide Vaccine Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Meningococcal Polysaccharide Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Meningococcal Polysaccharide Vaccine Production Comparison
        4.2.1 United States VS China: Meningococcal Polysaccharide Vaccine Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Meningococcal Polysaccharide Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Meningococcal Polysaccharide Vaccine Consumption Comparison
        4.3.1 United States VS China: Meningococcal Polysaccharide Vaccine Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Meningococcal Polysaccharide Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Meningococcal Polysaccharide Vaccine Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Meningococcal Polysaccharide Vaccine Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Meningococcal Polysaccharide Vaccine Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Meningococcal Polysaccharide Vaccine Production (2018-2023)
    4.5 China Based Meningococcal Polysaccharide Vaccine Manufacturers and Market Share
        4.5.1 China Based Meningococcal Polysaccharide Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Meningococcal Polysaccharide Vaccine Production Value (2018-2023)
        4.5.3 China Based Manufacturers Meningococcal Polysaccharide Vaccine Production (2018-2023)
    4.6 Rest of World Based Meningococcal Polysaccharide Vaccine Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Meningococcal Polysaccharide Vaccine Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Meningococcal Polysaccharide Vaccine Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Meningococcal Polysaccharide Vaccine Production (2018-2023)

5 Market Analysis by Type
    5.1 World Meningococcal Polysaccharide Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Polysaccharide Meningtitis AC
        5.2.2 Meningitis ACYW
    5.3 Market Segment by Type
        5.3.1 World Meningococcal Polysaccharide Vaccine Production by Type (2018-2029)
        5.3.2 World Meningococcal Polysaccharide Vaccine Production Value by Type (2018-2029)
        5.3.3 World Meningococcal Polysaccharide Vaccine Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Meningococcal Polysaccharide Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 6 Months-15Year
        6.2.2 over 3 Year
        6.2.3 over 2 Year
        6.2.4 over 3 Months
    6.3 Market Segment by Application
        6.3.1 World Meningococcal Polysaccharide Vaccine Production by Application (2018-2029)
        6.3.2 World Meningococcal Polysaccharide Vaccine Production Value by Application (2018-2029)
        6.3.3 World Meningococcal Polysaccharide Vaccine Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Sanofi
        7.1.1 Sanofi Details
        7.1.2 Sanofi Major Business
        7.1.3 Sanofi Meningococcal Polysaccharide Vaccine Product and Services
        7.1.4 Sanofi Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Sanofi Recent Developments/Updates
        7.1.6 Sanofi Competitive Strengths & Weaknesses
    7.2 Bio-Med
        7.2.1 Bio-Med Details
        7.2.2 Bio-Med Major Business
        7.2.3 Bio-Med Meningococcal Polysaccharide Vaccine Product and Services
        7.2.4 Bio-Med Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Bio-Med Recent Developments/Updates
        7.2.6 Bio-Med Competitive Strengths & Weaknesses
    7.3 CanSinoBIO
        7.3.1 CanSinoBIO Details
        7.3.2 CanSinoBIO Major Business
        7.3.3 CanSinoBIO Meningococcal Polysaccharide Vaccine Product and Services
        7.3.4 CanSinoBIO Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 CanSinoBIO Recent Developments/Updates
        7.3.6 CanSinoBIO Competitive Strengths & Weaknesses
    7.4 Walvax Biotechnology
        7.4.1 Walvax Biotechnology Details
        7.4.2 Walvax Biotechnology Major Business
        7.4.3 Walvax Biotechnology Meningococcal Polysaccharide Vaccine Product and Services
        7.4.4 Walvax Biotechnology Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Walvax Biotechnology Recent Developments/Updates
        7.4.6 Walvax Biotechnology Competitive Strengths & Weaknesses
    7.5 Chongqing Zhifei Biological
        7.5.1 Chongqing Zhifei Biological Details
        7.5.2 Chongqing Zhifei Biological Major Business
        7.5.3 Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Product and Services
        7.5.4 Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Chongqing Zhifei Biological Recent Developments/Updates
        7.5.6 Chongqing Zhifei Biological Competitive Strengths & Weaknesses
    7.6 Chengdu Kanghua Biological Products
        7.6.1 Chengdu Kanghua Biological Products Details
        7.6.2 Chengdu Kanghua Biological Products Major Business
        7.6.3 Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Product and Services
        7.6.4 Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Chengdu Kanghua Biological Products Recent Developments/Updates
        7.6.6 Chengdu Kanghua Biological Products Competitive Strengths & Weaknesses
    7.7 Changsheng Biotechnology
        7.7.1 Changsheng Biotechnology Details
        7.7.2 Changsheng Biotechnology Major Business
        7.7.3 Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Product and Services
        7.7.4 Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Changsheng Biotechnology Recent Developments/Updates
        7.7.6 Changsheng Biotechnology Competitive Strengths & Weaknesses
    7.8 CanSinoBIO
        7.8.1 CanSinoBIO Details
        7.8.2 CanSinoBIO Major Business
        7.8.3 CanSinoBIO Meningococcal Polysaccharide Vaccine Product and Services
        7.8.4 CanSinoBIO Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 CanSinoBIO Recent Developments/Updates
        7.8.6 CanSinoBIO Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Meningococcal Polysaccharide Vaccine Industry Chain
    8.2 Meningococcal Polysaccharide Vaccine Upstream Analysis
        8.2.1 Meningococcal Polysaccharide Vaccine Core Raw Materials
        8.2.2 Main Manufacturers of Meningococcal Polysaccharide Vaccine Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Meningococcal Polysaccharide Vaccine Production Mode
    8.6 Meningococcal Polysaccharide Vaccine Procurement Model
    8.7 Meningococcal Polysaccharide Vaccine Industry Sales Model and Sales Channels
        8.7.1 Meningococcal Polysaccharide Vaccine Sales Model
        8.7.2 Meningococcal Polysaccharide Vaccine Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Meningococcal Polysaccharide Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Meningococcal Polysaccharide Vaccine Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Meningococcal Polysaccharide Vaccine Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Meningococcal Polysaccharide Vaccine Production Value Market Share by Region (2018-2023)
    Table 5. World Meningococcal Polysaccharide Vaccine Production Value Market Share by Region (2024-2029)
    Table 6. World Meningococcal Polysaccharide Vaccine Production by Region (2018-2023) & (K Doses)
    Table 7. World Meningococcal Polysaccharide Vaccine Production by Region (2024-2029) & (K Doses)
    Table 8. World Meningococcal Polysaccharide Vaccine Production Market Share by Region (2018-2023)
    Table 9. World Meningococcal Polysaccharide Vaccine Production Market Share by Region (2024-2029)
    Table 10. World Meningococcal Polysaccharide Vaccine Average Price by Region (2018-2023) & (US$/Dose)
    Table 11. World Meningococcal Polysaccharide Vaccine Average Price by Region (2024-2029) & (US$/Dose)
    Table 12. Meningococcal Polysaccharide Vaccine Major Market Trends
    Table 13. World Meningococcal Polysaccharide Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Doses)
    Table 14. World Meningococcal Polysaccharide Vaccine Consumption by Region (2018-2023) & (K Doses)
    Table 15. World Meningococcal Polysaccharide Vaccine Consumption Forecast by Region (2024-2029) & (K Doses)
    Table 16. World Meningococcal Polysaccharide Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Meningococcal Polysaccharide Vaccine Producers in 2022
    Table 18. World Meningococcal Polysaccharide Vaccine Production by Manufacturer (2018-2023) & (K Doses)
    Table 19. Production Market Share of Key Meningococcal Polysaccharide Vaccine Producers in 2022
    Table 20. World Meningococcal Polysaccharide Vaccine Average Price by Manufacturer (2018-2023) & (US$/Dose)
    Table 21. Global Meningococcal Polysaccharide Vaccine Company Evaluation Quadrant
    Table 22. World Meningococcal Polysaccharide Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Meningococcal Polysaccharide Vaccine Production Site of Key Manufacturer
    Table 24. Meningococcal Polysaccharide Vaccine Market: Company Product Type Footprint
    Table 25. Meningococcal Polysaccharide Vaccine Market: Company Product Application Footprint
    Table 26. Meningococcal Polysaccharide Vaccine Competitive Factors
    Table 27. Meningococcal Polysaccharide Vaccine New Entrant and Capacity Expansion Plans
    Table 28. Meningococcal Polysaccharide Vaccine Mergers & Acquisitions Activity
    Table 29. United States VS China Meningococcal Polysaccharide Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Meningococcal Polysaccharide Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Doses)
    Table 31. United States VS China Meningococcal Polysaccharide Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Doses)
    Table 32. United States Based Meningococcal Polysaccharide Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Meningococcal Polysaccharide Vaccine Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Meningococcal Polysaccharide Vaccine Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Meningococcal Polysaccharide Vaccine Production (2018-2023) & (K Doses)
    Table 36. United States Based Manufacturers Meningococcal Polysaccharide Vaccine Production Market Share (2018-2023)
    Table 37. China Based Meningococcal Polysaccharide Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Meningococcal Polysaccharide Vaccine Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Meningococcal Polysaccharide Vaccine Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Meningococcal Polysaccharide Vaccine Production (2018-2023) & (K Doses)
    Table 41. China Based Manufacturers Meningococcal Polysaccharide Vaccine Production Market Share (2018-2023)
    Table 42. Rest of World Based Meningococcal Polysaccharide Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Meningococcal Polysaccharide Vaccine Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Meningococcal Polysaccharide Vaccine Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Meningococcal Polysaccharide Vaccine Production (2018-2023) & (K Doses)
    Table 46. Rest of World Based Manufacturers Meningococcal Polysaccharide Vaccine Production Market Share (2018-2023)
    Table 47. World Meningococcal Polysaccharide Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Meningococcal Polysaccharide Vaccine Production by Type (2018-2023) & (K Doses)
    Table 49. World Meningococcal Polysaccharide Vaccine Production by Type (2024-2029) & (K Doses)
    Table 50. World Meningococcal Polysaccharide Vaccine Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Meningococcal Polysaccharide Vaccine Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Meningococcal Polysaccharide Vaccine Average Price by Type (2018-2023) & (US$/Dose)
    Table 53. World Meningococcal Polysaccharide Vaccine Average Price by Type (2024-2029) & (US$/Dose)
    Table 54. World Meningococcal Polysaccharide Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Meningococcal Polysaccharide Vaccine Production by Application (2018-2023) & (K Doses)
    Table 56. World Meningococcal Polysaccharide Vaccine Production by Application (2024-2029) & (K Doses)
    Table 57. World Meningococcal Polysaccharide Vaccine Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Meningococcal Polysaccharide Vaccine Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Meningococcal Polysaccharide Vaccine Average Price by Application (2018-2023) & (US$/Dose)
    Table 60. World Meningococcal Polysaccharide Vaccine Average Price by Application (2024-2029) & (US$/Dose)
    Table 61. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 62. Sanofi Major Business
    Table 63. Sanofi Meningococcal Polysaccharide Vaccine Product and Services
    Table 64. Sanofi Meningococcal Polysaccharide Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Sanofi Recent Developments/Updates
    Table 66. Sanofi Competitive Strengths & Weaknesses
    Table 67. Bio-Med Basic Information, Manufacturing Base and Competitors
    Table 68. Bio-Med Major Business
    Table 69. Bio-Med Meningococcal Polysaccharide Vaccine Product and Services
    Table 70. Bio-Med Meningococcal Polysaccharide Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Bio-Med Recent Developments/Updates
    Table 72. Bio-Med Competitive Strengths & Weaknesses
    Table 73. CanSinoBIO Basic Information, Manufacturing Base and Competitors
    Table 74. CanSinoBIO Major Business
    Table 75. CanSinoBIO Meningococcal Polysaccharide Vaccine Product and Services
    Table 76. CanSinoBIO Meningococcal Polysaccharide Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. CanSinoBIO Recent Developments/Updates
    Table 78. CanSinoBIO Competitive Strengths & Weaknesses
    Table 79. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
    Table 80. Walvax Biotechnology Major Business
    Table 81. Walvax Biotechnology Meningococcal Polysaccharide Vaccine Product and Services
    Table 82. Walvax Biotechnology Meningococcal Polysaccharide Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Walvax Biotechnology Recent Developments/Updates
    Table 84. Walvax Biotechnology Competitive Strengths & Weaknesses
    Table 85. Chongqing Zhifei Biological Basic Information, Manufacturing Base and Competitors
    Table 86. Chongqing Zhifei Biological Major Business
    Table 87. Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Product and Services
    Table 88. Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Chongqing Zhifei Biological Recent Developments/Updates
    Table 90. Chongqing Zhifei Biological Competitive Strengths & Weaknesses
    Table 91. Chengdu Kanghua Biological Products Basic Information, Manufacturing Base and Competitors
    Table 92. Chengdu Kanghua Biological Products Major Business
    Table 93. Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Product and Services
    Table 94. Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Chengdu Kanghua Biological Products Recent Developments/Updates
    Table 96. Chengdu Kanghua Biological Products Competitive Strengths & Weaknesses
    Table 97. Changsheng Biotechnology Basic Information, Manufacturing Base and Competitors
    Table 98. Changsheng Biotechnology Major Business
    Table 99. Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Product and Services
    Table 100. Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Changsheng Biotechnology Recent Developments/Updates
    Table 102. CanSinoBIO Basic Information, Manufacturing Base and Competitors
    Table 103. CanSinoBIO Major Business
    Table 104. CanSinoBIO Meningococcal Polysaccharide Vaccine Product and Services
    Table 105. CanSinoBIO Meningococcal Polysaccharide Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 106. Global Key Players of Meningococcal Polysaccharide Vaccine Upstream (Raw Materials)
    Table 107. Meningococcal Polysaccharide Vaccine Typical Customers
    Table 108. Meningococcal Polysaccharide Vaccine Typical Distributors
List of Figure
    Figure 1. Meningococcal Polysaccharide Vaccine Picture
    Figure 2. World Meningococcal Polysaccharide Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Meningococcal Polysaccharide Vaccine Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Meningococcal Polysaccharide Vaccine Production (2018-2029) & (K Doses)
    Figure 5. World Meningococcal Polysaccharide Vaccine Average Price (2018-2029) & (US$/Dose)
    Figure 6. World Meningococcal Polysaccharide Vaccine Production Value Market Share by Region (2018-2029)
    Figure 7. World Meningococcal Polysaccharide Vaccine Production Market Share by Region (2018-2029)
    Figure 8. North America Meningococcal Polysaccharide Vaccine Production (2018-2029) & (K Doses)
    Figure 9. Europe Meningococcal Polysaccharide Vaccine Production (2018-2029) & (K Doses)
    Figure 10. China Meningococcal Polysaccharide Vaccine Production (2018-2029) & (K Doses)
    Figure 11. Japan Meningococcal Polysaccharide Vaccine Production (2018-2029) & (K Doses)
    Figure 12. Meningococcal Polysaccharide Vaccine Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Meningococcal Polysaccharide Vaccine Consumption (2018-2029) & (K Doses)
    Figure 15. World Meningococcal Polysaccharide Vaccine Consumption Market Share by Region (2018-2029)
    Figure 16. United States Meningococcal Polysaccharide Vaccine Consumption (2018-2029) & (K Doses)
    Figure 17. China Meningococcal Polysaccharide Vaccine Consumption (2018-2029) & (K Doses)
    Figure 18. Europe Meningococcal Polysaccharide Vaccine Consumption (2018-2029) & (K Doses)
    Figure 19. Japan Meningococcal Polysaccharide Vaccine Consumption (2018-2029) & (K Doses)
    Figure 20. South Korea Meningococcal Polysaccharide Vaccine Consumption (2018-2029) & (K Doses)
    Figure 21. ASEAN Meningococcal Polysaccharide Vaccine Consumption (2018-2029) & (K Doses)
    Figure 22. India Meningococcal Polysaccharide Vaccine Consumption (2018-2029) & (K Doses)
    Figure 23. Producer Shipments of Meningococcal Polysaccharide Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Meningococcal Polysaccharide Vaccine Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Meningococcal Polysaccharide Vaccine Markets in 2022
    Figure 26. United States VS China: Meningococcal Polysaccharide Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Meningococcal Polysaccharide Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Meningococcal Polysaccharide Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Meningococcal Polysaccharide Vaccine Production Market Share 2022
    Figure 30. China Based Manufacturers Meningococcal Polysaccharide Vaccine Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Meningococcal Polysaccharide Vaccine Production Market Share 2022
    Figure 32. World Meningococcal Polysaccharide Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Meningococcal Polysaccharide Vaccine Production Value Market Share by Type in 2022
    Figure 34. Polysaccharide Meningtitis AC
    Figure 35. Meningitis ACYW
    Figure 36. World Meningococcal Polysaccharide Vaccine Production Market Share by Type (2018-2029)
    Figure 37. World Meningococcal Polysaccharide Vaccine Production Value Market Share by Type (2018-2029)
    Figure 38. World Meningococcal Polysaccharide Vaccine Average Price by Type (2018-2029) & (US$/Dose)
    Figure 39. World Meningococcal Polysaccharide Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 40. World Meningococcal Polysaccharide Vaccine Production Value Market Share by Application in 2022
    Figure 41. 6 Months-15Year
    Figure 42. over 3 Year
    Figure 43. over 2 Year
    Figure 44. over 3 Months
    Figure 45. World Meningococcal Polysaccharide Vaccine Production Market Share by Application (2018-2029)
    Figure 46. World Meningococcal Polysaccharide Vaccine Production Value Market Share by Application (2018-2029)
    Figure 47. World Meningococcal Polysaccharide Vaccine Average Price by Application (2018-2029) & (US$/Dose)
    Figure 48. Meningococcal Polysaccharide Vaccine Industry Chain
    Figure 49. Meningococcal Polysaccharide Vaccine Procurement Model
    Figure 50. Meningococcal Polysaccharide Vaccine Sales Model
    Figure 51. Meningococcal Polysaccharide Vaccine Sales Channels, Direct Sales, and Distribution
    Figure 52. Methodology
    Figure 53. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Meningococcal Polysaccharide Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Meningococcal Polysaccharide Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 27 Feb 2023

date Pharma & Healthcare

Meningococcal polysaccharide diphtheria conjugate vaccine is an active immunizing agent used to prevent infection by certain groups of meningococcal bacteria.

Global Meningococcal Polysaccharide Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Meningococcal Polysaccharide Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 11 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Meningococcal Polysaccharide Vaccine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Meningococcal Polysaccharide Vaccine Supply, Demand and Key Producers, 2024-2030

Global Meningococcal Polysaccharide Vaccine Supply, Demand and Key Producers, 2024-2030

date 09 Feb 2024

date Pharma & Healthcare

The global Meningococcal Polysaccharide Vaccine market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Meningococcal Polysaccharide Vaccine

Group ACYW135 Meningococcal Polysaccharide Vaccine

Group A and Group C Meningococcal Polysaccharide Vaccine

Group A and C Meningococcal Polysaccharide Vaccine

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>